Selecting a scientifically robust and regulatory-aligned partner for peptide characterization is one of the most critical decisions for any generic […]
The presence of nitrosamine impurities in pharmaceutical products has raised significant regulatory concerns globally, pushing the need for reliable, science-driven
Introduction Nitrosamine Impurity Limits for Health Canada Submissions Nitrosamines are chemical compounds typically formed under specific conditions involving nitrites and
Introduction In the evolving landscape of pharmaceutical regulations, Nitrosamine Impurity Analysis for FDA Approval has become a non-negotiable requirement. Ever
FDA Approval and Nitrosamine Impurity Analysis: How to Ensure Your Product Passes Read More »
Pharmaceutical manufacturers, API producers, and drug product developers must stay vigilant to ensure their products are free from harmful contaminants.
Achieve Regulatory Compliance with Nitrosamine Testing Services: A Buyer’s Guide Read More »
Introduction: The Rising Need for Nitrosamine Impurity Testing for Drug Products Nitrosamines have emerged as a major safety concern in
Eliminating Risk: Comprehensive Nitrosamine Impurity Testing for Drug Products Read More »
Introduction The emergence of nitrosamines as genotoxic impurities has triggered global regulatory scrutiny, necessitating a proactive approach to nitrosamine risk
Nitrosamine Risk Assessment for NDAs: Regulatory Requirements and Testing Solutions Read More »
Introduction As Health Canada tightens its regulatory oversight on pharmaceutical impurities, nitrosamine impurity testing for Health Canada has become a
Introduction When pharmaceutical and biotechnology companies seek Extractables and Leachables (E&L) testing services , one aspect is to have idea
Cost of Extractables and Leachables Testing: What Influences the Price? Read More »
Introduction: Extractables and Leachables (E&L) Testing for Inhalation and Nasal Drug Products has become a regulatory imperative in 2025. Given
